Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fluarix / Influsplit SSW 2009/2010 immunogenicity and safety study in adults and elderly
2009-010811-34Phase 3Completed
- Sponsor
- GSK
- Start
- Mar 2009
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 3, open-label trial of Fluarix in influenza (2 arms), sponsored by GSK. Primary endpoints: Humoral immune response against each vaccine strain and Safety and reactogenicity. Started Mar 2009; status: completed.
02
Drugs
Fluarix
03
Conditions
influenza
Beyond the preview
Go deeper on 2009-010811-34.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-010811-34.